Eisenstadt Richard I 4
4 · Altimmune, Inc. · Filed Jan 3, 2023
Insider Transaction Report
Form 4
Eisenstadt Richard I
Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-12-31−12,500→ 37,500 total→ Common Stock, par value $0.0001 (12,500 underlying) - Tax Payment
Common Stock, par value $0.0001
2022-12-31$16.45/sh−3,028$49,811→ 10,838 total - Exercise/Conversion
Common Stock, par value $0.0001
2022-12-31+12,500→ 13,866 total
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- [F2]Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
- [F3]The RSUs become vested and exercisable over four (4) years with 25% of the shares vesting on December 31, 2022, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.